Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nutrex Research, Inc.
WARNING LETTER
•Nutrex Research, Inc.•August 18, 2017

Nutrex Research, Inc. – FDA Warning Letter, Aug 18, 2017

Record Details

This FDA Warning Letter, dated April 24, 2015, addresses Nutrex Research, Inc.'s product Adipodex, labeled as a dietary supplement. The primary concern is the inclusion of 4-Amino-2-Methylpentane Citrate (DMBA) as a declared dietary ingredient.

The FDA states that DMBA is a "new dietary ingredient" requiring notification under section 413(a)(2) of the Federal Food, Drug, and Cosmetic Act (the Act) and 21 CFR 190.6. To the FDA's knowledge, DMBA was not lawfully marketed as a dietary ingredient before October 15, 1994, nor has it been present in the food supply as an unchemically altered food article. Since the required notification was not submitted, Adipodex is deemed adulterated under sections 402(f)(1)(B) and 413(a) of the Act.

Furthermore, the FDA indicates a lack of evidence establishing DMBA's safety when used as a dietary ingredient, leading to further adulteration under the same sections due to inadequate information to assure safety. The letter also notes that synthetically produced DMBA, if used, does not meet the definition of a "dietary ingredient" under section 201(ff)(1) of the Act, as it is not a vitamin, mineral, amino acid,

Company
Nutrex Research, Inc.
Inspection date
August 18, 2017
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · 9ee7e4c3-4117-490c-a49b-33c82fb77320

Violation Codes10
21 U.S.C. 331(a)21 U.S.C. 321(ff)21 U.S.C. 321(ff)(1)21 U.S.C. 350b(a)(2)21 CFR 190.621 U.S.C. 350b21 U.S.C. 342(f)21 U.S.C. 342(f)(1)(B)21 U.S.C. 331(v)21 U.S.C. 332

Full citation text and observation details available on the Dashboard.

Other documents for Nutrex Research, Inc.
  • WARNING_LETTER - 2012-04-24April 24, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nutrex Research, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.